|
|
|
|
Interferon Alpha Can Delay Full Onset Of Type I Diabetes: UT Researcher
Interferon Alpha Can Delay Full Onset Of Type I : UT Researcher Medical Medical Medical Worldwide Search / Oncology hip Funny Useful Websites details of 26,000 UK specialists medical software Ask a Doctor and Disease Information from...
|
|
|
Joint Replacement Patients With Diabetes Greatly Benefit From Controlled Glucose
Joint Replacement Patients With Greatly Benefit From Controlled Glucose Medical Medical Medical Worldwide Search / Oncology hip Funny Useful Websites details of 26,000 UK specialists medical software Ask a Doctor and Disease Information from...
|
|
|
Treatment That Significantly Slows Progression Of Eye Damage In Persons With Type 1 Diabetes - University Of M
Treatment That Significantly Slows Progression Of Eye Damage In Persons With Type 1 - University Of Minnesota Medical Medical Medical Worldwide Search / Oncology hip Funny Useful Websites details of 26,000 UK specialists medical...
|
|
|
Diabetic Retinopathy Stopped By Natural Compound
Researchers at the University of Oklahoma Health Sciences Center have found a way to use a natural compound to stop one of the leading causes of blindness in the United States.The research appears online this month in the journal ...
|
|
|
Know the Warning Signs for Type 1 Diabetes
Jul 3, 2009 - 9:00:12 AM Sign up for our Ezine For Email Marketing you can trust Unfortunately, the number of children with type 1 diabetes Ms.Sotomayor was diagnosed at age 8 is on the upswing. In type 1 diabetes, also...
|
|
|
Diabetics urged to stay on popular insulin Lantus
Dr Louis Philipson has already started fielding calls from worried diabetics after new studies of 300,000 patients released recently suggested the Sanofi-Aventis insulin drug Lantus might raise the risk of cancer.'I think the deluge is...
|
|
|
Interferon alpha found to preserve insulin secretion and delay the onset of type I diabetes
Diabetes Care, a journal of the ADA Type I diabetes comes about when the immune system, in a fit of paranoia, decides that beta cells of the pancreas are enemies of the state and must be destroyed.Interferon alpha (IFNa) seems...
|
|
|
FDA reviewing safety of Sanofi's Lantus insulin
TRENTON, N.J.The Food and Drug Administration said Wednesday it is reviewing data on the safety of Lantus, a synthetic insulin made by Sanofi-Aventis SA. The move comes after a recent, widely publicized study raised the possibility the...
|
|
|
ONGLYZA' (Saxagliptin) Receives Positive Opinion In Europe For The Treatment Of Type 2 Diabetes
Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) announced that their marketing authorization application for ONGLYZA" (saxagliptin) received a positive opinion from the Committee for Medicinal Products for Human Use ...
|
|
|
'Jumping Gene' Diminishes The Effect Of A New Type 2 Diabetes Risk Gene
Research led by the German Institute of Human Nutrition (DIfE) has identified a new gene associated with diabetes, together with a mechanism that makes obese mice less susceptible to diabetes.A genomic fragment that occurs naturally in...
|
|
|
ONGLYZA (Saxagliptin) Receives Positive Opinion In Europe For The Treatment Of Type 2 Diabetes
Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) announced that their marketing authorization application for ONGLYZA (saxagliptin) received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP...
|
|
|
Interferon Alpha Can Delay Full Onset Of Type I Diabetes: UT Researcher
A low dose of oral interferon alpha shows promise in preserving beta cell function for patients with newly diagnosed type 1 diabetes, or juvenile diabetes, according to researchers at The University of Texas Medical School at Houston....
|
|
|
Joint Replacement Patients With Diabetes Greatly Benefit From Controlled Glucose
Diabetics undergoing total joint replacement often are at a higher risk of experiencing complications after surgery due to various pre-existing health conditions.According to a new study published in the July 2009 issue of The Journal of...
|
|
|
Gene Inhibition Helps to Normalize Type 2 Diabetes
In research that could lead to new approaches for the treatment of Type 2 diabetes, a research team has found that suppressing a liver enzyme that induces glucose production helped diminish the symptoms of the disease reducing blood...
|
|
|
Kids With Type 1 Diabetes Often Overweight
THURSDAY, July 2 (HealthDay News) -- Children with type 1 diabetes are more likely to be overweight than those without the disease, increasing their risk of serious health complications, researchers say.The finding is from a major...
|
|
|
DID YOU KNOW: FDA Approves ACTOplus met(R) XR Tablets for the Treatment of Type 2 Diabetes
Another 'not new' drug, but new combination added to the arsenal for treating diabetes.Takeda Pharmaceutical have announced that the FDA approved an extended-release version of the combination medication ACTOplus met(R) (pioglitazone HCl...
|
|
|
Diabetes risk high in children with persistent metabolic syndrome
MedWire News: Children with persistent metabolic syndrome have accelerated fat gain, increased insulin response to oral glucose, and decreased insulin sensitivity and beta-cell function, all indicators of progressively greater risk for ...
|
|
|
FDA Tells Patients to Stick With Diabetes Drug Linked to Cancer
WEDNESDAY, July 1 (HealthDay News) Despite recent studies suggesting that the injected diabetes drug Lantus (insulin glargine) might boost cancer risk, the U.S.Food and Drug Administration on Wednesday urged patients who are on the...
|
|
|
Treatment That Significantly Slows Progression Of Eye Damage In Persons With Type 1 Diabetes - University Of M
University of Minnesota Medical School researcher Michael Mauer, M.D., has found a treatment that significantly slows the progression of eye injury in people with type 1 diabetes, a common complication caused by this disease.By...
|
|
|
FDA reviewing safety of Sanofi's Lantus insulin
TRENTON, N.J.(AP) - The Food and Drug Administration said Wednesday it is reviewing data on the safety of Lantus, a synthetic insulin made by Sanofi-Aventis SA. The move comes after a recent, widely publicized study raised the...
|
|
|
Lantus Insulin: A Possible Link with Cancer - Requires Further Investigation
Using Vitamin C Plus Insulin to Stop Diabetes Damage Posted June 23, 2009 New Possible Bone Marrow Stem Cell Therapy for Diabetes Posted June 23, 2009 Body Chemistry Identifies Type 2 Risk Posted June 29, 2009 Test Your...
|
|
|
Lieberman Holds Juvenile Diabetes Hearing South Glastonbury Boy Testifies
WASHINGTON - Homeland Security and Governmental Affairs Committee Chairman Joe Lieberman, ID-Conn., held a hearing Wednesday about the impact of Type I diabetes on children and to amplify the need for a cure.The Senator singled out...
|
|
|
Depression Linked to Low Insulin Sensitivity in Type 2 Diabetes
Researchers at the University of Connecticut in Farmington report that depression is associated with low insulin sensitivity and that treatment of depression decreases insulin resistance.'Depressed subjects have a 37% increased risk of...
|
|
|
FDA Tells Patients to Stick With Diabetes Drug Linked to Cancer
WEDNESDAY, July 1 (HealthDay News) -- Despite recent studies suggesting that the injected diabetes drug Lantus (insulin glargine) might boost cancer risk, the U.S.on Wednesday urged patients who are on the medication to continue using it....
|
|
|
Joint Replacement Patients with Diabetes Greatly Benefit from Controlled Glucose
Newswise Diabetics undergoing often are at a higher risk of experiencing complications after surgery due to various pre-existing health conditions.According to a new study published in the July 2009 issue of , those complications are less...
|
